Background: Chrysin is a natural flavonoid which has been identified as a candidate anti-cancer agent due to its inhibitory effect on a variety of cancer cells, including targeted inhibition of sphere formation in hepatocellular carcinoma (HCC) cell lines. However, the mechanism by which chrysin modulates HCC spheres remains unclear. Materials and methods: In this study, we investigate the effect of chrysin on the regulation of SHP-1 and its downstream signal molecule STAT3 to explain the mechanism by which chrysin inhibits sphere formation of HCC cell lines. Results: Here, we found that SHP-1 protein expression was markedly down-regulated in the spheres from both SMMC-7721 and MHCC97H cells. Chrysin significantly inhibited sphere formation and upregulated the expression of SHP-1 protein in both SMMC-7721 and MHCC97H cells, as well as reduced p-STAT3 and Twist1 expressions in SMMC-7721 cells. Furthermore, knockdown of SHP-1 in SMMC-7721 cells resulted in the induction of p-STAT3 and Twist1 protein expression and antagonizing the inhibitory effect of chrysin on sphere formation in SMMC-7721 cells. Conclusion: Overall, the study findings demonstrated that chrysin acts as a candidate for the treatment of HCC through modulating SHP-1/STAT3 signaling pathway.
Introduction
Hepatocellular carcinoma (HCC) is one of the most common digestive system cancers, ranking as the fifth most common cause of cancer-related death worldwide. 1 Remarkably, HCC is the third for cancer mortality in China. 2 Despite advances in both diagnosis and treatment, the incidence and mortality of HCC continues to rise, thought to be caused by cancer stem cells (CSCs) that have been reported to possess capabilities for self-renewal, invasion, and tumorgenicity. 3, 4 Therefore, further investigation of biologic properties for CSCs may help to develop a new therapeutic approach for HCC patients.
Signal transducer and activator of transcription 3 (STAT3) is an oncogenic transcription factor and its phosphorylation has been observed in various malignancies, including prostate, liver, and colorectal cancers. 5, 6, 7 STAT3 activation is involved in multiple cellular progress, such as proliferation, apoptosis, and metastasis. 8, 9 It is worth noting that STAT3 plays an important role in inducing characteristics of CSCs. 10, 11 Src homology region 2 domain containing phosphatase 1 (SHP-1) belongs to a family of non-receptor protein tyrosine phosphatases (PTPs) and expresses highly in normal lymphoid cells, but is diminished in several of cancer cell lines. 12 Several evidences showed SHP-1 acts as a tumor suppressor. [13] [14] [15] and has been reported to catalyze dephosphorylation of STAT3 at the tyrosine 705 (Tyr705) residue and to directly cause silencing of STAT3. 16, 17 Accordingly, a loss of SHP-1 can result in activation of STAT3, therefore SHP-1 adjustment to STAT3 activation may be an appealing anti-cancer strategy. Chrysin (5, 7-dihydroxyflavone) is a natural flavone widely found propolis and honey. Chrysin is well documented to possess multiple biological activities, such as antioxidant, anti-inflammatory, especially anticancer effects. [18] [19] [20] Recently, a number of studies have certified that chrysin played the inhibitory effects in drug resistance, invasion, proliferation, and apoptosis in cancer. 21 However, the mechanisms underlying the regulation of STAT3 activation by chrysin are also unclear. In the present study, we explored whether chrysin can inhibit sphere formation in SMMC-7721 cells through modulation of the SHP-1/STAT3 signaling pathway.
Materials and methods

Regents and cell culture
Chrysin was obtained from Sigma-Aldrich (St. Louis, MO, USA) and diluted with dimethyl sulfoxide to a stock concentration of 10 mmol·L
. Other media used for cell culture were from GIBCO, Life Technologies (Grand Island, NY, USA).
HCC cell lines SMMC-7721 cell and MHCC97H cell were obtained from the Cell Bank of Chinese Academy of Sciences (Shanghai, China), and cultured in DMEM medium contained 10% FBS, 100 U/mL penicillin, and 100 U/mL streptomycin at 37°C and 5% CO 2 .
Sphere formation assay SMMC-7721 cells and MHCC97H cells were harvested from normal culture and plated into ultra-low attachment six-well plates (Corning Inc., Corning, NY, USA, 5000 cells/well). These plates were incubated with serum-free DMEM/F12 medium containing 20 ng/mL of hrbFGF and hrEGF, 5 μg/mL insulin, 0.4% BSA, 0.2% B27, and 100 U/mL penicillin and streptomycin at 37°C with 5% CO 2 . After incubation for 6 days, the spheres that exceed 20 cells were counted, and the sphere formation efficiency was calculated as (number of spheres formed/number of cells seeded) ×100%.
Western blot
Western blot was performed as described previously. 7 
SHP-1 knockdown
The siRNA components used in experiments, control (sc-37007) and SHP-1 (sc-44101 primers: sense-GCAGGAG UCCGAGGAUACATT, antisense-UGUACCUCGGACUC CUGCTT)) were purchased from Santa Cruz Biotechnology (Santa Cruz, MO, USA). These siRNA were subsequently transfected into cells using the Lipofectamine2000 reagent (Invitrogen, Grand Island, NY, USA) according to the manufacturer's instructions.
Statistical analysis
All experimental data are presented as mean ± SD. All quantitative results were entered into SPSS 16.0 (SPSS Inc, Chicago, IL, USA) to perform statistical analysis. Student's t-test and one-way ANOVA were used for data analysis. p<0.05 was considered statistically significant. All experiments were repeated three times. Results
Expressions of SHP-1 in spheres as well as a monolayer of HCC cell lines
It has been reported that SHP-1 plays an important role in cancer progression. 12 In order to assess SHP-1 protein expression in HCC-derived spheres, expressions of SHP-1 in both the spheres and monolayer of SMMC-7721 cell line or MHCC97H cell line were analyzed using western blot. We find that SHP-1 protein expression is down-regulated in the spheres compared to the monolayer of both SMMC-7721 ( Figure 1A ) and MHCC97H cell line ( Figure 1B ), suggesting that SHP-1 may be a potential target for inhibition of sphere formation in HCC cells.
Effect of chrysin on sphere formation in HCC cell lines
To evaluate whether chrysin suppressed the selfrenewal capability of HCC cells, SMMC-7721 cells and MHCC97H cells were treated with chrysin (0.0, 10.0, 20.0, 40.0 μM) for 24 hrs and then cultured using sphere-forming culture. Figure 2 indicates that chrysin dose-dependently decreased the sphere formation rate in both SMMC-7721 cells and MHCC97H cells.
Effects of chrysin on SHP-1 expression in HCC cells
To investigate the underlining mechanism of chrysin, SMMC-7721 cells and MHCC97H cells were treated with or without chrysin for 24 hrs or 48 hrs, and then the SHP-1 expression was detected by western blot. Interestingly, Figure 3 shows that SHP-1 expressions are elevated with increasing drug concentration in both SMMC-7721 cells and MHCC97H cells.
Effect of chrysin on the expressions of p-STAT3 and Twist1 in SMMC-7721 cells
Previous study demonstrated that 8-Bromo-7-methoxychrysin could inhibit the stemness of CSLCs derived from SMMC-7721 cells by blocking the STAT3/Twist axis. 28 Many studies have found that SHP-1 tumor suppression may result from its direct downregulating of p-STAT3 Tyr705. To explain the potential mechanism by which chrysin inhibits sphere formation of HCC cells, the expression levels of p-STAT3 and Twist1 in SMMC-7721 cells treated with or without chrysin were determined. We observe drastically down- 
Discussion
Here, we demonstrated, for the first time, that chrysin could inhibit sphere formation in HCC cells by suppressing STAT3 activation through upregulation of SHP-1 expression. This novel mechanism of chrysin suggests new insights for the design of HCC-associated targeted therapy.
Various studies have shown that chrysin exhibits antitumor activities in solid tumors. For example, inhibition of proliferation and promotion of apoptosis in human ovarian cancer cells via modulation of mitochondrial dysfunction, 29 suppression of prostate cancer cell proliferation via cell cycle arrest, 30 and induction of apoptosis in HCC cell lines. 31, 32 Similarly, we found that chrysin significantly inhibited sphere formation in SMMC-7721 cells. Given that sphere formation capability reflects the selfrenewal properties of CSCs, 33 chrysin might possess the potential to target inhibition of CSCs in HCC.
To the best of our knowledge, this is the first time that chrysin induced the expression of SHP-1 protein expression, indicating that SHP-1 may be a pivotal target molecule for the antitumor activity of chrysin. SHP-1 is known to be a negative regulator of STAT3 that participates in tumor progression. 34 Reports have shown that chrysin suppressed angiogenesis and overcomed TRAIL resistance in HCC via STAT3 singling. 25, 35 It was also reported that SHP-1 functions as a suppressor of TGF-β1-triggered EMT and metastasis via targeting p-STAT3 in HCC. 13 SPH-1/STAT3 signaling pathway was also involved in inducing autophagy in HCC cell lines. 36 And it was critically associated with the radiosensitivity of HCC cells. In this study, the first time, we determined that the inhibitory effects of chrysin on HCC involved in Our work demonstrated that SHP-1 expressions in spheres derived from SMMC-7721 cells, and MHCC97H cells are higher than in their parental cells. Chrysin induces the expression of SHP-1 and reduces STAT3 phosphorylation and Twist1 expression. Remarkably, we observe that SPH-1 siRNA transfection significantly abrogated the inhibitiory effect of chrysin on sphere formation. Together, these findings strongly indicate that SHP-1 is a gene that can repress self-renewal, and its activity can be mechanistically enhanced by chrysin. Finally, the elevated expression of SPH-1 is known to be an important inhibitor of p-STAT3 and Twist1 and may affect tumor development directly or indirectly.
In summary, our findings demonstrate that chrysin effectively inhibit sphere formation in HCC cells. Additionally, SHP-1 is shown to act as a key molecular mechanism of chrysin-inhibited self-renewal capability in HCC cells through its tyrosine phosphatase activity that negatively targets p-STAT3. Suppression of SHP-1/STAT3 signaling axis, therefore, might serve as a powerful potential therapeutic target for human HCC. 
